Develops wearable bioelectric devices for wound healing and pain reduction.
Sep 2023Revenue $256K/yrExpenses $2.87M/yr
No trend
Figures by year
When will Endonovo Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Sep 2023, revenue was $256K and expenses $2.87M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2022 | $135K | $3.40M | −$3.26M |
| Dec 2021 | $73.1K | $2.30M | −$2.23M |
| Dec 2020 | $166K | $3.08M | −$2.91M |
| Dec 2019 | $310K | $4.12M | −$3.81M |
| Dec 2018 | $83.3K | $4.24M | −$4.16M |
| Dec 2015 | $4.26K | $2.57M | −$2.56M |
| Dec 2014 | $24.2K | $2.22M | −$2.19M |
| Dec 2013 | $22.9K | $2.45M | −$2.43M |
| Dec 2012 | $30.6K | $1.77M | −$1.74M |
| Dec 2011 | $45.5K | $141K | −$95.5K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.